Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Operationalizing outcome measures of human papillomavirus vaccination among adolescents.

Odoh C, Sanderson M, Williams EA, Hull PC.

Public Health. 2018 Jun;159:129-132. doi: 10.1016/j.puhe.2018.02.022. Epub 2018 Mar 30.

2.

Correlates of HPV vaccine initiation and provider recommendation among male adolescents, 2014 NIS-Teen.

Landis K, Bednarczyk RA, Gaydos LM.

Vaccine. 2018 Jun 7;36(24):3498-3504. doi: 10.1016/j.vaccine.2018.04.075. Epub 2018 May 8.

3.

Sub-Regional Assessment of HPV Vaccination Among Female Adolescents in the Intermountain West and Implications for Intervention Opportunities.

Bodson J, Ding Q, Warner EL, Hawkins AJ, Henry KA, Kepka D.

Matern Child Health J. 2017 Jul;21(7):1500-1511. doi: 10.1007/s10995-017-2274-3.

PMID:
28092058
4.

Timing of HPV vaccine intervals among United States teens with consideration to the current ACIP schedule and the WHO 2-dose schedule.

Cloessner EA, Stokley S, Yankey D, Markowitz LE.

Hum Vaccin Immunother. 2016 Jun 2;12(6):1375-80. doi: 10.1080/21645515.2015.1110659. Epub 2015 Nov 20.

5.

Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey.

Ylitalo KR, Lee H, Mehta NK.

Am J Public Health. 2013 Jan;103(1):164-9. doi: 10.2105/AJPH.2011.300600. Epub 2012 Jun 14.

6.

Measuring Adolescent Human Papillomavirus Vaccine Coverage: A Match of Sexually Transmitted Disease Clinic and Immunization Registry Data.

Pathela P, Jamison K, Papadouka V, Kabir R, Markowitz LE, Dunne EF, Schillinger JA.

J Adolesc Health. 2016 Dec;59(6):710-715. doi: 10.1016/j.jadohealth.2016.07.021. Epub 2016 Sep 23.

PMID:
27671357
7.

Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States.

Adjei Boakye E, Lew D, Muthukrishnan M, Tobo BB, Rohde RL, Varvares MA, Osazuwa-Peters N.

Hum Vaccin Immunother. 2018;14(8):2016-2024. doi: 10.1080/21645515.2018.1467203. Epub 2018 Jun 1.

8.

A Comparison of Parent- and Provider-Reported Human Papillomavirus Vaccination of Adolescents.

Adjei Boakye E, Tobo BB, Osazuwa-Peters N, Mohammed KA, Geneus CJ, Schootman M.

Am J Prev Med. 2017 Jun;52(6):742-752. doi: 10.1016/j.amepre.2016.10.016. Epub 2016 Nov 24.

PMID:
27890518
9.

Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States.

Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J, Curtis RC, Markowitz L; Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Jul 25;63(29):620-4.

10.

Characteristics of Adolescents Lacking Provider-Recommended Human Papillomavirus Vaccination.

Krakow M, Beavis A, Cosides O, Rositch AF.

J Adolesc Health. 2017 May;60(5):619-622. doi: 10.1016/j.jadohealth.2016.11.028. Epub 2017 Jan 7.

PMID:
28073618
11.

Factors Associated with Increased HPV Vaccine Use in Rural-Frontier U.S. States.

Lai D, Ding Q, Bodson J, Warner EL, Kepka D.

Public Health Nurs. 2016 Jul;33(4):283-94. doi: 10.1111/phn.12223. Epub 2015 Aug 31.

12.

Area-based socioeconomic factors and Human Papillomavirus (HPV) vaccination among teen boys in the United States.

Henry KA, Swiecki-Sikora AL, Stroup AM, Warner EL, Kepka D.

BMC Public Health. 2017 Jul 14;18(1):19. doi: 10.1186/s12889-017-4567-2. Erratum in: BMC Public Health. 2017 Sep 22;17 (1):736.

13.

Concordance of adolescent human papillomavirus vaccination parental report with provider report in the National Immunization Survey-Teen (2008-2013).

Hirth J, Kuo YF, Laz TH, Starkey JM, Rupp RE, Rahman M, Berenson AB.

Vaccine. 2016 Aug 17;34(37):4415-21. doi: 10.1016/j.vaccine.2016.07.014. Epub 2016 Jul 18.

14.

Human Papillomavirus Infection and Vaccination.

Valentino K, Poronsky CB.

J Pediatr Nurs. 2016 Mar-Apr;31(2):e155-66. doi: 10.1016/j.pedn.2015.10.005. Epub 2015 Nov 14. Review.

PMID:
26586310
15.

Race-specific trends in HPV vaccinations and provider recommendations: persistent disparities or social progress?

Burdette AM, Webb NS, Hill TD, Jokinen-Gordon H.

Public Health. 2017 Jan;142:167-176. doi: 10.1016/j.puhe.2016.07.009. Epub 2016 Sep 1.

PMID:
27592005
16.

Provider communication and HPV vaccination: The impact of recommendation quality.

Gilkey MB, Calo WA, Moss JL, Shah PD, Marciniak MW, Brewer NT.

Vaccine. 2016 Feb 24;34(9):1187-92. doi: 10.1016/j.vaccine.2016.01.023. Epub 2016 Jan 24.

17.

Prevalence and predictors of human papillomavirus vaccination in adolescent girls.

Palli SR, Mehta S, Aparasu RR.

J Am Pharm Assoc (2003). 2012 Jan-Feb;52(1):52-8. doi: 10.1331/JAPhA.2012.10195.

PMID:
22257616
18.

Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma.

Herweijer E, Leval A, Ploner A, Eloranta S, Simard JF, Dillner J, Netterlid E, Sparén P, Arnheim-Dahlström L.

JAMA. 2014 Feb 12;311(6):597-603. doi: 10.1001/jama.2014.95.

PMID:
24519299
19.

Social inequalities in adolescent human papillomavirus (HPV) vaccination: a test of fundamental cause theory.

Polonijo AN, Carpiano RM.

Soc Sci Med. 2013 Apr;82:115-25. doi: 10.1016/j.socscimed.2012.12.020. Epub 2012 Dec 27.

PMID:
23337830
20.

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2017.

Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Mbaeyi SA, Fredua B, Stokley S.

MMWR Morb Mortal Wkly Rep. 2018 Aug 24;67(33):909-917. doi: 10.15585/mmwr.mm6733a1. Erratum in: MMWR Morb Mortal Wkly Rep. 2018 Oct 19;67(41):1164.

Supplemental Content

Support Center